Clinical trial
Evaluation of the Diagnostic Performance of Non-Invasive Prenatal Diagnosis for Single Gene Disorders
NCT06147414 is registered in ClinicalTrials.gov with Assistance Publique - Hôpitaux de Paris as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of the Diagnostic Performance of Non-Invasive Prenatal Diagnosis for Single Gene Disorders
- Lead sponsor
- Assistance Publique - Hôpitaux de Paris
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- October 23, 2024
- Completion date
- May 31, 2027
- Enrollment
- 550 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
autosomal recessive polycystic kidney disease, cystic fibrosis, fragile x syndrome, hemophilia a, hemophilia b, huntington disease, invasive prenatal diagnosis in a context of family history of single-gene disorders, including, mody2 diabetes, muscular dystrophy, becker, muscular dystrophy, duchenne, myotonic dystrophy, neurofibromatosis-noonan syndrome, proximal spinal muscular atrophy, sickle cell disease, x-linked hydrocephalus